James Zangrilli

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

Mario Castro, James Zangrilli, Michael E. Wechsler et al. · The Lancet Respiratory Medicine · 2015 · 1.2K citations

Life Sciences, Immunology, Pharmacotherapy +11

Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels

Leif Bjermer, Catherine Lemière, Jorge Máspero et al. · CHEST Journal · 2016 · 426 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma

Jonathan Corren, Steven F. Weinstein, Lindsay Janka et al. · CHEST Journal · 2016 · 383 citations

Medicine, Pharmacology, Pharmacotherapy +15

Characterization of Severe Asthma Worldwide

Eileen Wang, Michael E. Wechsler, Trung N. Tran et al. · CHEST Journal · 2019 · 331 citations · Full text

Public Health, Health Sciences, Clinical Epidemiology +10

Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies

J. Mark FitzGerald, Eugene R. Bleecker, Andrew Menzies‐Gow et al. · The Lancet Respiratory Medicine · 2017 · 317 citations

Medicine, Immunology, Pharmacology +13